Parkinson's disease dementia--a first step?
Press
Daniel Z
DZ
D000978:Antiparkinson Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D018450:Disease Progression; D006801:Humans; D020961:Lewy Body Disease / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D048448:Phenylcarbamates / Q000009:adverse effects / Q000627:therapeutic use*; D000068836:Rivastigmine
D000978:Antiparkinson Agents; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine